Creative Medical Technology Holdings, Inc. (CELZ) - מזומן למניה

סמל תאגידי ולוגו של Creative Medical Technology Holdings (CELZ)

Creative Medical Technology relies on a team of leading biologists whose research is supported by generous funding. The cash per share trend demonstrates capital liquidity, while the 0.90 metric confirms the current level of asset protection. High growth potential is driven by the licensing of regenerative patents, although strict FDA oversight limits the scaling pace of the StemSpine platform.

creativemedicaltechnology.com (CELZ) - יתרות מזומנים למניה מ-04.07.2022 עד 20.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור Creative Medical Technology Holdings (CELZ)

- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מסכם של החברה:Creative Medical Technology
מוצר מקורי של creativemedicaltechnology.com

For an investor in Creative Medical Technology (CELZ), this indicator serves as a measure of financial stability during the commercialization of cell technologies. The calculation is performed by dividing total net cash by the total number of shares, which reflects the cash position per share chart. An increase in this metric confirms liquidity, although an excess may signal low investment efficiency. In the context of treating urological and orthopedic pathologies, this reserve is critical for scaling licensing sales. A stable balance of funds guarantees business viability until the innovations achieve full market recognition.